In a bid to accelerate vaccination against COVID-19 in rural areas and small towns of the country, Pune-based vaccine maker Serum Institute of India (SII) has entered into a partnership with the industry body Confederation of Indian Industry (CII), reports Hindustan Times.
SII's chief executive Adar Poonawalla said that the partnership “will be a good way to close the gaps” as there is plenty of supply of Covishield doses available for distribution. He emphasised that it is essential that all stakeholders work together towards carrying out vaccinations.
CII's president TV Narendran said that the partnership with SII will help in catalysing the industry participation to reach out to the communities at large. He said that CII aims to connect community, hospital and corporates to fast-track vaccinations.
CII is also mapping the state-wise vaccination requirement and setting up inoculation camps focusing on reaching rural areas and second and third-tier cities.
Meanwhile, it should be noted that other than SII's Covishield, India is also using Bharat Biotech's Covaxin and Russian Sputnik V COVID-19 vaccines for nationwide inoculation drive.
An appeal from Swarajya
At Swarajya, we rely on our readers' support through subscriptions to sustain our media platform. Unlike larger conglomerates, we are unable to relentlessly chase advertising money — our model is largely built on your patronage.
Your support has never been more crucial. We work tirelessly to deliver 10-15 high-quality articles daily, ensuring you receive insightful content from 7 AM to 10 PM.
If you believe India's story has to be articulated in a way it has never been done before without shrugging it off, become a patron (or) subscribe now for ₹̶2̶4̶0̶0̶ ₹1999 and get 12 print issues, unlimited digital access for 1 year, a special India that is Bharat T-shirt (Offer ends soon).
We are counting on you!